NeuroPace, Inc. (NPCE)
8.22
+0.25
(+3.14%)
USD |
NASDAQ |
Nov 17, 16:00
8.35
+0.13
(+1.58%)
After-Hours: 20:00
NeuroPace Profit Margin (Quarterly) : -14.27% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.27% |
| June 30, 2026 | -27.16% |
| March 31, 2026 | -30.31% |
| December 31, 2025 | -10.26% |
| September 30, 2025 | -21.07% |
| June 30, 2025 | -51.36% |
| March 31, 2025 | -29.25% |
| December 31, 2024 | -24.46% |
| September 30, 2024 | -25.89% |
| June 30, 2024 | -39.02% |
| March 31, 2024 | -49.24% |
| December 31, 2023 | -34.42% |
| September 30, 2023 | -44.18% |
| June 30, 2023 | -55.26% |
| Date | Value |
|---|---|
| March 31, 2023 | -71.69% |
| December 31, 2022 | -87.15% |
| September 30, 2022 | -105.6% |
| June 30, 2022 | -124.4% |
| March 31, 2022 | -100.8% |
| December 31, 2021 | -97.24% |
| September 30, 2021 | -78.18% |
| June 30, 2021 | -67.25% |
| March 31, 2021 | -78.54% |
| December 31, 2020 | -42.95% |
| September 30, 2020 | -32.31% |
| June 30, 2020 | -115.1% |
| March 31, 2020 | -67.58% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -2.50% |
| Accuray, Inc. | 11.71% |
| Orthofix Medical, Inc. | -2.92% |
| ResMed, Inc. | 29.57% |
| Rockwell Medical, Inc. | -12.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -125.5% |
| Return on Assets | -15.98% |
| Return on Invested Capital | -22.13% |
| Gross Profit Margin (Quarterly) | 84.28% |
| Operating Margin (Quarterly) | -9.00% |
| Return on Net Operating Assets | -43.68% |